steady state for modified release [Regulatives / Guidelines]

posted by Kelen – Brazil, 2019-09-20 22:04 (2111 d 06:43 ago) – Posting: # 20636
Views: 6,809

I would like to ask help for understand the objetive of the steady state study when you are comparing a MR formulation with a IR formulation. The objective would be compare the effect of the accumulation? Is there any reason to conduct the study only with de highest dose?


Edit: Please follow the Forum’s Policy[Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,425 posts in 4,928 threads, 1,675 registered users;
44 visitors (0 registered, 44 guests [including 8 identified bots]).
Forum time: 04:47 CEST (Europe/Vienna)

No problem can stand the assault of sustained thinking.    Voltaire

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5